Biological Seed Treatment Market (2026-2036)
The global biological seed treatment market was valued at USD 1.91 billion in 2025. This market is estimated to reach USD 5.4 billion by 2036 from USD 2.11 billion in 2026, at a CAGR of 9.8% during the forecast period of 2026–2036.
- Published
- Mar 2026
- Pages
- 365
- Format
- PDF + Excel
- Report ID
- MRAGR - 104652
- Base year
- 2025
- 2025 · BASELINE
- $1.91B
- 2036
- $5.40B
- CAGR 2026–2036
- 9.8%
2025 baseline · 2026–2036 forecast at 9.8% CAGR · hover a bar for the value
Key highlights
The global biological seed treatment market is valued at USD 2.11 billion in 2026. This market is projected to reach USD 5.4 billion by 2036, growing at a CAGR of 9.8% during the forecast period of 2026–2036.
Based on type, the microbial seed treatment segment is expected to account for the largest share of the market in 2026. This segment includes bacterial and fungal seed treatments used for disease suppression, nutrient enhancement, and plant growth promotion. Microbial products have gained strong commercial acceptance due to their proven agronomic benefits and compatibility with integrated crop management systems.
Within the microbial segment, the bacterial seed treatments segment is the largest sub-category. Nitrogen-fixing Rhizobium and Bradyrhizobium inoculants are widely used in legume crops such as soybean and pulses, while Bacillus-based biological products are increasingly used for disease suppression and plant growth promotion in multiple crop types.
By formulation, liquid biological seed treatment formulations account for the largest share of the market due to their compatibility with commercial seed treatment equipment and ability to deliver high concentrations of active microorganisms. However, dry formulations, including wettable powders and water-dispersible granules, are gaining importance due to their improved shelf stability and simplified storage requirements.
Based on function, seed protection is the largest functional segment, as biological seed treatments are widely used to protect germinating seeds and seedlings from soil-borne pathogens during early growth stages. At the same time, seed enhancement applications, which include biostimulant-based treatments that promote root growth and nutrient uptake, are expected to register strong growth during the forecast period.
By crop type, cereals and grains are the largest application segment due to the extensive global cultivation of crops such as corn, wheat, and rice. Biological seed treatments are increasingly adopted in these crops to improve early plant establishment and reduce disease pressure.
By geography, North America is expected to account for the largest share of the global biological seed treatment market, driven by advanced seed treatment infrastructure, strong adoption of commercial seed technologies, and high awareness of biological crop inputs among farmers.
Asia-Pacific biological seed treatment market is poised to grow at the fastest CAGR during the forecast period, driven by expanding organic agriculture, increasing regulatory support for sustainable farming practices, and growing domestic biological product development in countries such as China and India.
Report summary
| Particulars | Details |
|---|---|
| Market Size by 2036 | USD 5.4 Billion |
| Market Size in 2025 (Base Year) | USD 1.91 Billion |
| Market Size in 2026 | USD 2.11 Billion |
| Market Growth Rate (2026–2036) | CAGR of ~9.8% |
| Format | PDF, Excel & Cloud Portal · 365 pages |
| Dominating Region (2026) | North America |
| Fastest Growing Region | Asia-Pacific |
| Base Year | 2025 |
| Forecast Period | 2026 to 2036 |
| Segments Covered | By Type: Microbial (Bacteria [Rhizobium, Bacillus, Pseudomonas, Other Bacteria]; Fungi [Trichoderma, Mycorrhizae, Other Fungi]; Others), Biochemical (Humic Acid, Seaweed Extracts, Amino Acid-Based Products, Other Biochemicals) · By Formulation: Liquid Formulation; Dry Formulation (Wettable Powder, Dry Flowable/Water-Dispersible Granule) · By Function: Seed Protection; Seed Enhancement · By Application Technique: Seed Coating; Seed Pelleting; Seed Priming; Seed Dressing · By Crop Type: Cereals & Grains (Corn/Maize, Wheat, Rice, Other Cereals & Grains); Oilseeds & Pulses (Soybean, Canola/Rapeseed, Sunflower, Cotton, Other Oilseeds & Pulses); Fruits & Vegetables; Other Crop Types · By Geography: North America; Europe; Asia-Pacific; Latin America; Middle East & Africa |
| Countries Covered | North America (U.S.; Canada; Mexico); Europe (Germany; France; U.K.; Italy; Spain; Rest of Europe); Asia-Pacific (China; India; Japan; Australia; South Korea; Rest of Asia-Pacific); Latin America (Brazil; Argentina; Rest of Latin America); Middle East & Africa |
| Key Companies | BASF SE, Bayer AG, Syngenta Group, Corteva Agriscience, Novonesis (formerly Novozymes A/S), UPL Limited, Koppert Biological Systems, Valent BioSciences LLC, Verdesian Life Sciences LLC, Plant Health Care plc, Rizobacter Argentina S.A. (part of Bioceres Crop Solutions), Marrone Bio Innovations (now part of Bioceres Crop Solutions), Certis USA LLC, Precision Laboratories LLC, Locus Agriculture, Indigo Ag Inc., BioConsortia Inc., Italpollina S.p.A. (Hello Nature Group), Incotec Group, and BioWorks Inc. |
Report overview
Segments covered: type, formulation, function, application technique, crop type. Regions: North America, Europe, Asia-Pacific, Latin America.
Biological seed treatment refers to the application of naturally derived biological agents or biochemical substances to seeds prior to planting to enhance plant health, protect seedlings from pathogens and pests, and improve crop establishment. These treatments typically contain beneficial microorganisms, such as bacteria and fungi or naturally derived biochemical compounds that promote plant growth and suppress harmful pathogens during early crop development.
Unlike conventional chemical seed treatments that rely on synthetic fungicides, insecticides, and nematicides, biological seed treatments operate through biological interactions between microorganisms, plant roots, and the surrounding soil microbiome. Beneficial bacterial species such as Bacillus, Rhizobium, and Pseudomonas colonize the rhizosphere and enhance nutrient uptake, nitrogen fixation, and plant defense responses. Similarly, beneficial fungi, including Trichoderma species and mycorrhizal fungi, provide biological control against soil-borne pathogens while improving plant access to water and soil nutrients. In addition, biochemical inputs such as humic substances, seaweed extracts, and amino acid–based biostimulants promote root development and improve plant tolerance to abiotic stresses.
Biological seed treatments are gaining importance within modern agricultural systems as farmers increasingly adopt sustainable crop protection solutions that reduce reliance on synthetic agrochemicals. The market is mainly driven by the growing regulatory pressure on conventional pesticides, rising consumer demand for residue-free food products, and the expansion of organic farming systems worldwide. Policies aimed at reducing pesticide use, including the European Union’s Farm to Fork Strategy, which targets a 50% reduction in chemical pesticide use by 2030, are encouraging the adoption of biological crop protection technologies.
The growth of the overall biological seed treatment market is also driven by technological advancements in microbial discovery, fermentation processes, and seed coating technologies. These innovations are enabling manufacturers to develop stable formulations with improved shelf life and enhanced field performance, expanding the commercial viability of biological seed treatment products.
Biological seed treatments are used across a wide range of crop categories, including major row crops such as corn, soybean, wheat, cotton, rice, and canola, as well as vegetables, fruits, and horticultural crops. Applications are typically carried out in commercial seed treatment facilities operated by seed companies or specialized service providers using automated seed coating systems, although on-farm seed treatment remains common in certain emerging agricultural markets.
The global biological seed treatment market was valued at USD 1.91 billion in 2025. This market is estimated to reach USD 5.4 billion by 2036 from USD 2.11 billion in 2026, at a CAGR of 9.8% during the forecast period of 2026–2036.
Report infographic
Market dynamics
5 factors across 2 forcesGrowing Demand for Organic Food and Expansion of Certified Organic Farmland
The expansion of organic agriculture is one of the key drivers for the growth of biological seed treatments market. According to the Research Institute of Organic Agriculture (FiBL) and IFOAM – Organics International, global organic farmland reached 98.9 million hectares in 2023, continuing a long-term expansion trend from approximately 11 million hectares in 1999. Organic certification frameworks, such as the EU Organic Regulation (EU) 2018/848, the USDA National Organic Program, and equivalent regulatory systems in Canada, Japan, India, and Brazil, significantly restrict the use of synthetic pesticides and fungicides in organic crop production. As a result, biological seed treatments based on microbial inoculants, plant extracts, and biochemical biostimulants is one of the primary seed-stage protection tools available to organic farmers.
The continued growth of organic farmland, driven by rising consumer demand for residue-free food and government sustainability programs, is therefore creating significant demand for biological seed treatment products.
Regulatory Restrictions on Chemical Seed Treatments Creating Demand for Biological Alternatives
Increasing regulatory scrutiny of synthetic crop protection chemicals is driving the transition toward biological seed treatment solutions. The European Union banned the outdoor use of three neonicotinoid insecticides—imidacloprid, clothianidin, and thiamethoxam—in 2018 due to their impact on pollinators. At the same time, the EU’s Farm to Fork Strategy aims to reduce the overall use and risk of chemical pesticides by 50% by 2030, reinforcing the policy shift toward biological crop protection technologies. Similar regulatory trends are emerging globally. In the U.S., the Environmental Protection Agency (EPA) continues to evaluate older pesticide active ingredients through its registration review process while maintaining comparatively streamlined approval pathways for biological pesticides. These policy trends are encouraging agricultural input suppliers and seed companies to drive the development and commercialization of biological seed treatments that provide disease suppression and plant growth benefits without triggering regulatory restrictions.
Rising Pressure to Increase Agricultural Productivity on Limited Arable Land
Global food demand is increasing as the world population continues to expand. According to the United Nations Department of Economic and Social Affairs (UN DESA), the global population is projected to reach 8.5 billion by 2030 and approximately 9.7 billion by 2050. At the same time, the availability of arable land per capita has declined significantly over the past several decades. According to the Food and Agriculture Organization (FAO), global demand for cereals is expected to exceed 3 billion tonnes by 2050, compared with roughly 2.8 billion tonnes in the early 2020s, showcasing increasing demand for both food and livestock feed. These structural pressures are driving the adoption of technologies that improve crop productivity without expanding cultivated land area. Biological seed treatments contribute to this objective by improving seed germination, protecting seedlings from soil-borne pathogens, and enhancing nutrient uptake and root development through plant growth-promoting microorganisms.
Table of contents
13 chapters · 185 sections · 365 pages · click to expandGeographic analysis
North America
Largest shareNorth America is the largest market for biological seed treatments, driven by the advanced seed treatment infrastructure of the U.S. and high adoption of commercial hybrid seeds. The U.S. agricultural system relies heavily on professionally treated seeds, particularly for major row crops such as corn and soybean, where seed treatment is widely integrated into commercial seed distribution channels. The presence of leading agricultural input companies and biotechnology firms, combined with active biological research programs and supportive regulatory frameworks for biological pesticides, further drives the growth of the biological seed treatment market in this region. North America: Largest Market for Biological Seed Treatment
Europe
Europe is a major market for biological seed treatments due to the stringent environmental policies and the growing organic farming sector in the region. According to Eurostat, organic farming accounts for approximately 10% of total agricultural land in the European Union, with several countries exceeding this average. The EU’s long-term agricultural policy direction, including pesticide reduction targets under the Farm to Fork Strategy, is driving the transition toward biological crop protection technologies. Countries such as Germany, France, Italy, Spain, and the U.K. are the primary markets for biological seed treatments within the region. Europe: Regulatory-Driven Market Transformation
Asia-Pacific
Fastest growthThe Asia-Pacific biological seed treatment market is expected to grow at the fastest CAGR from 2026 to 2036. The factors such as the rapid expansion of sustainable agriculture initiatives, increasing awareness of biological inputs, and government programs promoting reduced pesticide use are driving market growth in the region. India and China are the largest markets within Asia-Pacific due to their extensive agricultural land areas, expanding organic farming sectors, and growing domestic biological crop protection industries. Other countries such as Japan, Australia, and South Korea are mature markets characterized by strict food safety standards and increasing adoption of sustainable agricultural technologies. Asia-Pacific: Fastest-Growing Market for Biological Seed Treatment
Competitive landscape
- BASF SE
- Bayer AG
- Syngenta Group
- Corteva Agriscience
- Novonesis (formerly Novozymes A/S)
- UPL Limited
- Koppert Biological Systems
- Valent BioSciences LLC
- Verdesian Life Sciences LLC
- Plant Health Care plc
- Certis USA LLC
- Precision Laboratories LLC
- Locus Agriculture
- Indigo Ag Inc.
- BioConsortia Inc.
- Italpollina S.p.A. (Hello Nature Group)
- Incotec Group
- BioWorks Inc.
Frequently asked questions
The global biological seed treatment market was valued at USD 1.91 billion in 2025 and is estimated to reach USD 2.11 billion in 2026. The market is projected to reach USD 5.37 billion by 2036, growing at a CAGR of 9.8% during the forecast period (2026–2036).
Cite this report
Meticulous Research. (2026). Biological Seed Treatment Market - Global Opportunity Analysis And Industry Forecast (2026-2036) (Report No. MRAGR - 104652). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/biological-seed-treatment-market-5338